EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Prevalence of Second Neoplasms in Patients with Non-Aldosterone Producing Adrenocortical Lesions

Paraskevi Tripolitsioti, Ariadni Spyroglou iD, Odysseas Violetis, Panagiota Konstantakou, Eleni Chouliara, Grigoria Betsi, Konstantinos Iliakopoulos iD, Eleni Memi iD, Konstantinos Bramis iD, Denise Kolomodi, Paraskevi Xekouki, Manousos Konstadoulakis und 2 weitere

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms262010167 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Paraskevi Tripolitsioti und 13 weiteren Autor:innen. Beteiligte Einrichtung: Intensive Care Unit, 1st Department of Respiratory Medicine, National and Kapodistrian University of Athens, Sotiria Hospital, 11527 Athens, Greece. Hauptthemen laut MEDLINE: Neoplasms, Second Primary, Adrenal Gland Neoplasms, Adrenal Cortex Neoplasms, Adrenocortical Adenoma. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Over the last few decades, due to improvement in imaging techniques, the increased detection of adrenal incidentalomas is observed. Non-aldosterone producing adrenal adenomas (NAPACAs) often co-exist with second benign or malignant lesions. In the present study, we aimed to assess the presence of second neoplasms, both benign and malignant, in patients with NAPACAs, and to investigate possible correlations with clinical parameters, hormonal characteristics and the emergence of comorbidities. A total of 130 NAPACA patients were included in this single-center retrospective study. In this cohort, 35.4% of NAPACA patients carried any second neoplasm (either benign or malignant) whereas, 26.9% had a second malignant neoplasm. Cortisol levels after 1 mg overnight dexamethasone suppression test (F-ODS) were significantly higher in patients without a second neoplasm (p = 0.02), and this finding was consistent even when categorizing patients with and without malignancies (p = 0.02). In line with this observation, ACTH/F-ODS levels were significantly higher in patients with second malignancies (p < 0.05). Interestingly, the presence of mild autonomous cortisol secretion tended to be lower in patients with second malignancies (p = 0.08). No remarkable differences in the comorbidities of NAPACA patients with and without a second neoplasm were documented. Further prospective studies will be needed to elucidate the role of mild hypercortisolemia on the development of these second tumors in NAPACA patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neoplasms, Second PrimaryAdrenal Gland NeoplasmsAdrenal Cortex NeoplasmsAdrenocortical AdenomaHumansMaleFemaleMiddle AgedAgedRetrospective StudiesPrevalenceHydrocortisoneAdultAldosterone

Stichwörter der Autor:innen

non-aldosterone producing adrenal adenomas (NAPACA)second malignancysecond neoplasm

Substanzen

HydrocortisoneAldosterone

Autor:innen und Institutionen

  • Intensive Care Unit, 1st Department of Respiratory Medicine, National and Kapodistrian University of Athens, Sotiria Hospital, 11527 Athens, Greece.
  • 2nd Department of Surgery, Aretaieio Athens Hospital, Medical School, National and Kapodistrian University of Athens, 11528 Athens, Greece.
  • Endocrinology & Diabetes Clinic, University Hospital of Heraklion, University of Crete, School of Medicine, 71500 Crete, Greece.
  • European Neuroendocrine Tumor Society (ENETS) Center of Excellence, Ekpa-Laiko Center, 11527 Athens, Greece.
  • IATROPOLIS Private Medical Center, 11521 Athens, Greece.
  • Unit of Endocrinology, Diabetes Mellitus and Metabolism, Aretaieion Hospital, Faculty of Medicine, National and Kapodistrian University of Athens, 11528 Athens, Greece.

ORCID-Profile: Ariadni Spyroglou, Konstantinos Iliakopoulos, Eleni Memi, Konstantinos Bramis, George Mastorakos, Krystallenia I Alexandraki

Zitieren

APA

Tripolitsioti, P., Spyroglou, A., Violetis, O., Konstantakou, P., Chouliara, E., Betsi, G., Iliakopoulos, K., Memi, E., Bramis, K., Kolomodi, D., Xekouki, P., Konstadoulakis, M., Mastorakos, G., & Alexandraki, K. I. (2025). The Prevalence of Second Neoplasms in Patients with Non-Aldosterone Producing Adrenocortical Lesions. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms262010167

Vancouver

Tripolitsioti P, Spyroglou A, Violetis O, Konstantakou P, Chouliara E, Betsi G, et al. The Prevalence of Second Neoplasms in Patients with Non-Aldosterone Producing Adrenocortical Lesions. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms262010167

BibTeX
@article{Tripolitsioti2025,
  author = {Tripolitsioti, Paraskevi and Spyroglou, Ariadni and Violetis, Odysseas and Konstantakou, Panagiota and Chouliara, Eleni and Betsi, Grigoria and Iliakopoulos, Konstantinos and Memi, Eleni and Bramis, Konstantinos and Kolomodi, Denise and Xekouki, Paraskevi and Konstadoulakis, Manousos and Mastorakos, George and Alexandraki, Krystallenia I},
  title = {The Prevalence of Second Neoplasms in Patients with Non-Aldosterone Producing Adrenocortical Lesions},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms262010167}
}
Kostenlos starten →